lenalidomide has been researched along with axitinib in 2 studies
| Studies (lenalidomide) | Trials (lenalidomide) | Recent Studies (post-2010) (lenalidomide) | Studies (axitinib) | Trials (axitinib) | Recent Studies (post-2010) (axitinib) |
|---|---|---|---|---|---|
| 3,532 | 725 | 2,850 | 765 | 145 | 683 |
| Protein | Taxonomy | lenalidomide (IC50) | axitinib (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase PLK4 | Homo sapiens (human) | 0.045 | |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.0658 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.046 | |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.0001 | |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.0001 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.0079 | |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | 0.47 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Arango, BA; Cohen, EE; Perez, CA; Raez, LE; Santos, ES | 1 |
1 review(s) available for lenalidomide and axitinib
| Article | Year |
|---|---|
Novel molecular targeted therapies for refractory thyroid cancer.
Topics: Angiogenesis Inhibitors; Anilides; Antineoplastic Agents; Axitinib; Benzamides; Benzenesulfonates; Benzoquinones; Bibenzyls; Boronic Acids; Bortezomib; Depsipeptides; ErbB Receptors; Gefitinib; Histone Deacetylase Inhibitors; HSP90 Heat-Shock Proteins; Humans; Hydroxamic Acids; Imatinib Mesylate; Imidazoles; Indazoles; Indoles; Lactams, Macrocyclic; Lenalidomide; Niacinamide; Oligonucleotides; Phenylurea Compounds; Piperazines; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrazines; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Quinolines; Receptor Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Sulfonamides; Sunitinib; Thalidomide; Thyroid Neoplasms; Valproic Acid; Vorinostat | 2012 |
1 other study(ies) available for lenalidomide and axitinib
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |